Molecular basis of Cancer (Mobac)
Research Projects
- Mapping the breakome of cancer cells
- Elucidating the role of gene products of CFSs in driving carcinogenesis
- Dissecting the role of various oncogenes in inducing replication stress
- Studying the role of the WWOX gene in cellular metabolism
- Mapping the Landscape of DNA DSBs
- Identify Cancer Vulnerabilities
- Develop Targeted Cancer Therapies
Enhance user experience with Advanced Tabs, allowing seamless content navigation. Organize information efficiently while keeping the interface clean and interactive. Perfect for FAQs, product details, or multi-section content.
Enhance user experience with Advanced Tabs, allowing seamless content navigation. Organize information efficiently while keeping the interface clean and interactive. Perfect for FAQs, product details, or multi-section content.
Enhance user experience with Advanced Tabs, allowing seamless content navigation. Organize information efficiently while keeping the interface clean and interactive. Perfect for FAQs, product details, or multi-section content.
Enhance user experience with Advanced Tabs, allowing seamless content navigation. Organize information efficiently while keeping the interface clean and interactive. Perfect for FAQs, product details, or multi-section content.
Enhance user experience with Advanced Tabs, allowing seamless content navigation. Organize information efficiently while keeping the interface clean and interactive. Perfect for FAQs, product details, or multi-section content.
A cornerstone of our research is to identify and understand the vulnerabilities introduced by DSBs in cancer cells. These vulnerabilities represent potential therapeutic targets that could be exploited to selectively kill cancer cells without harming normal cells.
Leveraging the vulnerabilities identified, our goal is to develop innovative therapeutic strategies that target the unique dependencies of cancer cells on certain DNA repair pathways. This includes the design of novel drugs and gene therapies that can enhance the efficacy of existing treatments and overcome resistance mechanisms.
What we do
Integrating expertise from four pioneering research fields
At the Aqeilan Lab, our primary research interest lies in the intricate landscape of DNA double-strand breaks (DSBs) and their critical role in cancer development and progression. DNA DSBs are among the most severe forms of DNA damage, and their precise repair is crucial for maintaining genomic integrity and avoiding genomic instability. When this repair process is compromised, it can lead to the accumulation of mutations and the initiation of cancer.
Role of Tumor Suppressor Gene Products of Common Fragile Sites in Human Diseases
Common fragile sites (CFSs) are large chromosomal regions identified by conventional cytogenetics as sequences prone to breakage in cells subjected to replication stress. The interest in CFSs stems from their key role in DNA damage, resulting in chromosomal rearrangements. The instability of CFSs was correlated with genome instability in precancerous lesions and during tumor progression. Two opposing views dominate the discussion regarding the role of CFSs. One school of thought suggested that genomic instability during cancer progression causes collateral damage to genes residing within CFSs, such as WWOX and FHIT. These genes are proposed to be unselected ‘‘passenger’’ mutations. The counter argument is that deletions and other genomic alterations in CFSs occur early in cancer development. Cancer cells with deletions in genes that span CFSs are then selectively expanded due to loss of tumor suppressor functions such as protection of genome stability, coordination of cell cycle or apoptosis.
Recent observations from our lab clearly suggest that gene products of CFSs play driver roles in cancer transformation. Furthermore, accumulating evidence links some of these products with metabolic diseases and neuropathy. Investigating the role of these gene products in human diseases is a major interest of our lab work. The ultimate goal of our research is hence to discover the genes and to elucidate the pathways that represent targets for the development of rational, specific and effective therapeutic approaches.
